PF-Atlas › Drugs › ELX/TEZ/IVA

ELX/TEZ/IVA

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Vertex Pharmaceuticals Incorporated

Overview

ELX/TEZ/IVA is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 8 tracked IPF clinical trials.

ELX/TEZ/IVA clinical trials

NCT05153317 (Phase 3)NCT04545515 (Phase 3)NCT05274269 (Phase 3)NCT03691779 (Phase 3)NCT04702360 (Not specified)NCT04362761 (Phase 3)NCT04105972 (Phase 3)NCT04058210 (Not specified)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about ELX/TEZ/IVA for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.